Article Details

Circulating antiphospholipid antibodies drive endothelial cell activation in COVID-19

Retrieved on: 2021-01-26 04:07:30

Tags for this article:

Click the tags to see associated articles and topics

Circulating antiphospholipid antibodies drive endothelial cell activation in COVID-19. View article details on hiswai:

Excerpt

Importantly, this results from this study also suggest other potential therapies, including monoclonal antibody-mediated depletion of plasmablasts, the ...

Article found on: www.news-medical.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo